Cholangitis
MONDO:0004789An acute or chronic inflammatory process affecting the biliary tract.
Also known as: biliary tract infection, biliary tree inflammation, cholangitis, inflammation of biliary tree
142 clinical trials for this condition and its sub-types, 17 tagged with Cholangitis itself.
Follow this condition to get notified about new trialsWhere it sits in the disease tree
Browse by category →Sub-types of Cholangitis
-
Cholecystitis 35 trials · 65 incl. sub-types
4 sub-types
- Acute cholecystitis 35 trials
- Acalculous cholecystitis 0 trials
- Emphysematous cholecystitis 0 trials
- Xanthogranulomatous cholecystitis 0 trials
-
Sclerosing cholangitis 3 trials · 57 incl. sub-types
5 sub-types
- Primary sclerosing cholangitis 54 trials Sub-types →
- Secondary sclerosing cholangitis 2 trials
- IgG4-related sclerosing cholangitis 0 trials
- Isolated neonatal sclerosing cholangitis 0 trials
- Neonatal ichthyosis-sclerosing cholangitis syndrome 0 trials
-
Acute cholangitis 7 trials · 42 incl. sub-types
1 sub-type
- Acute cholecystitis 35 trials
-
Autoimmune cholangitis 1 trial
-
Ascending cholangitis 0 trials
-
Chronic cholangitis 0 trials
-
Pericholangitis 0 trials
-
Suppurative cholangitis 0 trials
Most studied deeper sub-types
-
Can a new drug rescue the liver when standard therapy fails?
Disease control CompletedThis phase 2 trial is testing an experimental drug called HTD1801 (BUDCA) in adults with primary biliary cholangitis (PBC) who haven't responded adequately to standard treatment. The goal is to see if the drug can safely lower alkaline phosphatase (ALP) levels, a key marker of li…
Phase 2 • Sponsor: HighTide Therapeutics (Hong Kong) Limited • Aim: Disease control
Last updated Aug 27, 2026 00:00 UTC
-
Could one day of antibiotics be enough for bile duct infections?
Disease control CompletedThis study looked at 410 patients with a bile duct infection (cholangitis) who had a procedure to drain the bile duct. It compared giving antibiotics for just 1 day versus the usual 4 to 7 days. The goal was to see if the shorter course is just as good at curing the infection, wh…
Sponsor: Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) • Aim: Disease control
Last updated Jun 27, 2026 13:07 UTC
-
Could a common arthritis drug help PSC patients?
Disease control CompletedThis study tested whether sulfasalazine, a drug used for arthritis, can improve liver health and symptoms in people with primary sclerosing cholangitis (PSC) who also have inflammatory bowel disease. 32 adults across the US took either the drug or a placebo for a set time. Resear…
Phase 2 • Sponsor: Brigham and Women's Hospital • Aim: Disease control
Last updated Jun 27, 2026 11:00 UTC
-
Disposable scope could cut infection risk in ERCP
Knowledge-focused CompletedThis study tested a new single-use duodenoscope (aScope) in 59 patients at high risk of infection after ERCP, a procedure to treat bile duct problems. The goal was to see if the scope works well and to gather information on costs and complications. The results could help decide i…
Sponsor: Nottingham University Hospitals NHS Trust • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:12 UTC